WHO BACKS REGENERON DRUG FOR COVID-19, URGES ACTION ON PRICE
Fri 24 September 2021: The World Health Organisation (WHO) has added the Regeneron antibody drug cocktail – casirivimab and imdevimab – to its list of treatments for people with COVID-19, urging the manufacturer to reduce the price and ensure equitable distribution. Clinical studies showed the drug combination was effective in patients who were not severely […]
Continue Reading
